“Preventing cardiovascular morbidity and mortality in cancer patients”
Currently, there are over 30 million cancer survivors worldwide. Cancer survivorship is expected to grow by 30%, and it is estimated that about 2 million Australians by 2040 will be living beyond cancer. This is due to improvements in cancer screening, effective treatments and the aging of the population. Cancer survivors often experience long-term negative consequences of their cancer and cancer treatment, specifically cardiovascular disease (CVD). Patients with cancer are at significantly higher risk of developing CVD than people without cancer. In this session, the Newcastle Centre of Excellence in Cardio-oncology will be discussing strategies, from discovery science, clinical/population science and clinical service implementation, that aims to improve the quality of life and overall survival of cancer patients by preventing cardiovascular morbidity and mortality in patients living with, through and beyond cancer.

Speakers
Professor Doan Ngo. Co-Director, Newcastle Centre of Excellence in Cardio-Oncology, Hunter Medical Research Institute, University of Newcastle
Professor Aaron Sverdlov. Co-Director, Newcastle Centre of Excellence in Cardio-Oncology, Hunter Medical Research Institute, University of Newcastle
Dr Trent Williams. Clinical Nurse Consultant in Cardiology, Hunter New England Health